
News|Slideshows|September 26, 2024
Emerging Research in Prostate Cancer Imaging — September 2024
Author(s)Diagnostic Imaging Staff
Catch up on the most-well viewed prostate imaging content in September 2024.
Advertisement
Touching on a variety of topics in prostate cancer imaging, ranging from Phase 3 trial results for 177Lu-PSMA-617 in taxane-naïve patients with mCRPC to a new meta-analysis comparing PSMA PET/CT to mpMRI in detecting biomechanical recurrence of PCa, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for September 2024.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
New Imaging Platform Allows Single-Integration Access to Multiple AI Vendors
2
Is bpMRI Sufficient for Assessing PI-RADS 3 Lesions?
3
Can Contrast-Enhanced Mammography Offer a Viable Option for Pre-Op Assessment of Pathologic Nipple Involvement?
4
Fujifilm Sonosite Unveils Next-Generation Point-of-Care Ultrasound Device
5






























